do glp-1 cause cancer medications (the ones often talked about for weight loss and diabetes) are making headlines again—but for a completely different reason. 💭 New studies are looking into how these medications might be GLP-1R Agonists for Weight Loss

WHO expands access through 2025 Essential Medicines Lists The World Health Organization (WHO) has published its 2025 Essential Medicines Lists (EMLs), marking a significant step in the recognition of medicines that address pressing global health needs

Consider the form of glutathione used (such as reduced glutathione or liposomal glutathione) and the presence of other supporting ingredients that enhance its absorption and bioavailability

[1] [2] GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion : They stimulate the pancreas to release insulin when blood glucose levels are elevated, helping to lower blood sugar in a glucose-dependent manner Suppressing glucagon release : They reduce the secretion of glucagon, a hormone that raises blood glucose, thereby preventing excessive glucose production by the liver Slowing gastric emptying : They delay the rate at which food leaves the stomach, leading to more gradual glucose absorption and increased feelings of fullness Reducing appetite : They act on areas of the brain involved in appetite regulation, helping to decrease food intake [2] [22] Commonly prescribed GLP-1 receptor agonists in the UK include semaglutide (Ozempic for diabetes, Wegovy for weight management, Rybelsus as an oral formulation), dulaglutide (Trulicity), liraglutide (Victoza for diabetes, Saxenda for weight management), and exenatide (Byetta, Bydureon)

Only if old eating patterns return